CUMULATIVE RESULTS
Cumulative results from isolates from all hospitals of the network are presented
Only the first isolate per patient and species is being processed.

July-December 2001
PERCENT (%) RESISTANCE
TO SELECTED ANTIBIOTICS BY HOSPITAL
 
Acinetobacter spp
   Ceftazidime (all clinical specimens)
  Amikacin (all clinical specimens)
  Ciprofloxacin (all clinical specimens)
  Imipenem (all clinical specimens)
  Multiresistance (all clinical specimens)
  Blood isolates (results from all hospitals)
Pseudomonas aeruginosa
  Ceftazidime (all clinical specimens)
  Amikacin (all clinical specimens)
  Ciprofloxacin (all clinical specimens)
  Imipenem (all clinical specimens)
  Multiresistance (all clinical specimens)
  Blood isolates (results from all hospitals)
Enterobacter spp
  Ceftazidime (all clinical specimens)
  Tobramycin (all clinical specimens)
  Ciprofloxacin (all clinical specimens)
  Multiresistance (all clinical specimens)
  Blood isolates (results from all hospitals)
S. aureus
  MRSA (all clinical specimens)
  MRSA to Gentamicin (all clinical specimens)
  Blood isolates (results from all hospitals)
Klebsiella pneumoniae
   Ceftazidime (all clinical specimens)
  Cefoxitin (all clinical specimens)
  Ciprofloxacin (all clinical specimens)
  Tobramycin (all clinical specimens)
  Multiresistance (all clinical specimens)
  Blood isolates (results from all hospitals)
Enterococci
  Vancomycin (all clinical specimens)
  Streptomycin (all clinical specimens)
  Gentamicin (all clinical specimens)
  Blood isolates (results from all hospitals)
E. coli
  Ciprofloxacin (all clinical specimens)
  Nalidixic (all clinical specimens)
  Blood isolates (results from all hospitals)

DISTRIBUTION OF BACTERIAL SPECIES
All clinical specimens
  Bacterial species by hospital (wards)
  Bacterial species by hospital (ICU)
Blood isolates
  Bacterial species by hospital (wards)
  Bacterial species by hospital (ICU)
Blood cultures
  Isolated microorganisms by type of ward